IDEX (IEX) Q4 Earnings Surpass Estimates, Revenues Down Y/Y

In this article:

IDEX Corporation’s IEX fourth-quarter 2023 adjusted earnings of $1.83 per share surpassed the Zacks Consensus Estimate of adjusted earnings of $1.78. On a year-over-year basis, the bottom line decreased approximately 9% from the year-ago quarter’s figure of earnings of $2.01 per share due to the higher effective tax rate. It also exceeded management’s projection of $1.74-$1.79 per share.

Revenue Details

In the quarter under review, IDEX’s net sales of $788.9 million outperformed the Zacks Consensus Estimate of $769 million. However, the top line decreased 3% year over year. Organic sales in the quarter decreased 6% year over year, lower than the 8-9% decline expected by the company. Acquisitions/divestitures boosted sales by 3%.

IEX reports net sales under three business segments, the results of which are discussed below:

Revenues from the Fluid & Metering Technologies segment totaled $299.1 million, increasing 3.9% year over year. Our estimate for segmental revenues was $282.2 million. Organic sales were up 3%. Foreign currency translation left a positive impact of 1%.

Revenues from the Health & Science Technologies segment totaled $312.7 million, indicating a year-over-year decline of 11%. Our estimate for segmental revenues was $309.8 million. Organic sales in the quarter declined 19% year over year, while acquired assets boosted sales by 7%. Foreign currency translation left a positive impact of 1%.

Revenues from the Fire & Safety/Diversified Products segment totaled $179 million, rising 5% year over year. Our estimate for segmental revenues was $175.2 million. The results were aided by a 3% increase in organic sales. Foreign currency translation left a positive impact of 2%.

IDEX Corporation Price, Consensus and EPS Surprise

IDEX Corporation Price, Consensus and EPS Surprise
IDEX Corporation Price, Consensus and EPS Surprise

IDEX Corporation price-consensus-eps-surprise-chart | IDEX Corporation Quote

Margin Profile

In the quarter under review, IDEX’s cost of sales decreased 2.8% year over year to $452.1 million. The gross profit was $336.8 million, down 2.6% year over year, while the gross margin was 42.7% compared with 42.6% reported in the year-ago quarter.

Selling, general and administrative expenses increased 2.7% year over year to $173.6 million. Adjusted EBITDA in the quarter under review decreased 7% year over year to $203.6 million. The adjusted EBITDA margin decreased 120 bps year over year to 25.8%.

The operating income was $160.5 million, down 8.3% year over year, whereas the margin was 20.3%, down 130 bps year over year. Interest expenses in the quarter decreased 4.1% year over year to $11.6 million.

Balance Sheet and Cash Flow

While exiting the fourth quarter, IDEX’s cash and cash equivalents were $534.3 million compared with $430.2 million recorded at the end of fourth-quarter 2022. Long-term borrowings were $1.33 billion compared with $1.47 billion recorded at the end of fourth-quarter 2022.

In 2023, IDEX generated net cash of $716.7 million from operating activities, increasing 28.6% from the year-ago period. Capital used for purchasing property, plant and equipment was $89.9 million compared with $68 million in 2022. In 2023, free cash flow was $626.8 million, up 28% year over year.

IEX paid out dividends totaling $190.7 million in 2023, up 7.5% year over year. The company repurchased common stock worth $24.2 million in the quarter.

It spent $311.8 million on acquisitions in 2023.

Outlook

For first-quarter 2024, IDEX anticipates adjusted earnings to be $1.70-$1.75 per share.

On a GAAP basis, IEX predicts earnings to be $1.45-$1.50 per share and a 6-7% decline in organic sales from the respective year-ago readings.

For 2024, IDEX anticipates adjusted earnings to be $8.15-$8.45 per share. The figure represents an increase from $8.22 per share reported in 2023. On a GAAP basis, earnings are predicted to be $7.15-$7.45 per share.

Organic sales are predicted to decline 0-2% in 2024.

Zacks Rank & Other Stocks to Consider

IDEX currently carries a Zacks Rank #2 (Buy).

A few other top-ranked companies from the same space are discussed below:

Parker-Hannifin Corporation PH presently carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

PH delivered a trailing four-quarter average earnings surprise of 14.4%. In the past 60 days, the Zacks Consensus Estimate for its 2023 earnings has increased 2.7%.

Flowserve Corporation FLS presently has a Zacks Rank of 2. FLS delivered a trailing four-quarter average earnings surprise of 27.3%. In the past 60 days, the Zacks Consensus Estimate for Flowserve’s 2023 earnings has remained steady.

Applied Industrial Technologies, Inc. AIT presently carries a Zacks Rank #2. It has a trailing four-quarter average earnings surprise of 10.4%. The Zacks
Consensus Estimate for AIT’s fiscal 2024 (ending June 2024) earnings remained steady in the past 60 days.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Parker-Hannifin Corporation (PH) : Free Stock Analysis Report

Flowserve Corporation (FLS) : Free Stock Analysis Report

Applied Industrial Technologies, Inc. (AIT) : Free Stock Analysis Report

IDEX Corporation (IEX) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Advertisement